Results 81 to 90 of about 2,784 (211)

Pharmacological treatment for buerger's disease [PDF]

, 2016
Background Buerger's disease (thromboangiitis obliterans) is a non-atherosclerotic, segmental inflammatory pathology that most commonly affects the small and medium sized arteries, veins, and nerves in the upper and lower extremities.
Baptista-Silva, Jose C. C., Cacione, Daniel G., Macedo, Cristiane R.   +2 more
core   +2 more sources

Segmented colon ischemia associated with thromboangiitis obliterans

São Paulo Medical Journal
A necrose isquêmica do colo associada à tromboangeite obliterante é rara e grave, com uma mortalidade elevada. A tromboangeite obliterante ocorre em pacientes jovens e as manifestações digestivas, raras nesta moléstia, ocorrem posteriormente aos ...
Francisco de Saltes Collet e Silva, Lucilia Heloisa Simardi   +1 more
doaj   +1 more source

Dicumarol [PDF]

, 1945
Thesis (M.D.)--Boston ...
Steel, Robert MacDonald
core  

Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS):study protocol for a randomised controlled trial [PDF]

, 2015
BACKGROUND: We have recently completed an evaluation of the safety and feasibility of intravenous delivery of autologous bone marrow in patients with progressive multiple sclerosis (MS).
Ben-Shlomo, Yoav, Blackmore, Stuart, Cottrell, David A, Evangelou, Nikos, Guttridge, Martin G, Kane, Nick M, Marks, David I, Metcalfe, Chris, Miflin, Gail, Morgan, Paul S, Owen, Denise, Redondo, Juliana, Rice, Claire M, Sarkar, Pamela, Scolding, Neil J, Walsh, Peter, Wilkins, Alastair   +16 more
core   +1 more source

Thromboangiitis Obliterans: 110 Years Old and Little Progress Made

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
See Article by Le Joncour et al.
Jeffrey W. Olin
doaj   +1 more source

Serum Lipoprotein (a) levels in Thromboangiitis Obliterans: A case control study [PDF]

, 2014
BACKGROUND: Thromboangiitis obliterans is a vasculopathy with limited management options. Lipoprotein (a) has been reported to be elevated in these patients.
Prerit Thomas Jacob,
core  

Smoking characteristics and cessation in patients with thromboangiitis obliterans

Monaldi Archives for Chest Disease, 2016
Aim. Describe the smoking characteristics and the results of a smoking intervention programme involving 27 cigarette smokers with Thromboangiitis Obliterans (TAO). Methods.
C.A. Jiménez-Ruiz, L.C. Dale, J. Astray Mochales, L. Velázquez Buendía, I. de Granda Orive, A. Guirao García   +5 more
doaj   +1 more source

Cancer pulmonaire au cours d’une thromboangéite oblitérante de Léo Buerger [PDF]

, 2016
Notre objectif est de rapporter une observation particulière de néoplasie pulmonaire survenant au cours d'une angéite oblitérante de Léo Buerger. Il s'agit d'un patient de 42 ans, grand tabagique (30 PA) diagnostiqué ayant la maladie de Buerger devant l ...
Bouomrani, S, Béji, M, Nouma, H, Slama, A   +3 more
core   +3 more sources

Ocular Manifestations of Buerger’s Disease – A Review of Current Knowledge

Clinical Ophthalmology, 2022
Urszula Szydełko-Paśko,1 Joanna Przeździecka-Dołyk,1,2 Rafał Małecki,3 Andrzej Szuba,3 Marta Misiuk-Hojło1 1Department of Ophthalmology, Wroclaw Medical University, Wrocław, Poland; 2Department of ...
Szydełko-Paśko U, Przeździecka-Dołyk J, Małecki R, Szuba A, Misiuk-Hojło M   +4 more
doaj  

Angiogenesis induction in Buerger's disease: a disease management double-edged sword?

Orphanet Journal of Rare Diseases, 2019
Due to unknown aetiology of Thromboangiitis obliterans (TAO), its effectively treating is challenging. However, angiogenesis induction is one of the acceptable treatments for TAO patients.
Bahare Fazeli, Shayan Keramat, Ladan Assadi, Hossein Taheri   +3 more
doaj   +1 more source